{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:31:37Z","timestamp":1767706297929,"version":"3.41.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,10,1]],"date-time":"2000-10-01T00:00:00Z","timestamp":970358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2000,10]]},"DOI":"10.1023\/a:1006482120049","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T02:03:28Z","timestamp":1040522608000},"page":"181-188","source":"Crossref","is-referenced-by-count":25,"title":["Local Anti-angiogenic Brain Tumor Therapies"],"prefix":"10.1007","volume":"50","author":[{"given":"Eric P.","family":"Sipos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Brem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"313835_CR1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/bjc.1977.49","volume":"35","author":"D Knighton","year":"1977","unstructured":"Knighton D, Ausprunk D, Tapper D, Folkman J: Avascular and vascular phases of tumour growth in the chick embryo. Br J Cancer 35: 347-356, 1977","journal-title":"Br J Cancer"},{"key":"313835_CR2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1084\/jem.136.2.261","volume":"136","author":"M Gimbrone","year":"1972","unstructured":"Gimbrone M, Leapman S, Cotran R, Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276, 1972","journal-title":"J Exp Med"},{"key":"313835_CR3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.138.4.745","volume":"138","author":"J Folkman","year":"1973","unstructured":"Folkman J, Hochberg M: Self-regulation of growth in three dimensions. J Exp Med 138: 745-753, 1973","journal-title":"J Exp Med"},{"key":"313835_CR4","first-page":"89","volume":"1032","author":"CH Blood","year":"1990","unstructured":"Blood CH, Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118, 1990","journal-title":"Biochim Biophys Acta"},{"key":"313835_CR5","first-page":"821","volume-title":"Inflammation: Basic Principles and Clinical Correlates","author":"J Folkman","year":"1992","unstructured":"Folkman J, Brem H: Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: Basic Principles and Clinical Correlates. Raven Press, Ltd., New York, 1992, pp 821-839"},{"key":"313835_CR6","first-page":"467","volume":"46","author":"J Folkman","year":"1986","unstructured":"Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes Memorial Award lecture. Cancer Res 46: 467-473, 1986","journal-title":"Cancer Res"},{"key":"313835_CR7","first-page":"505","volume":"55","author":"LT Furcht","year":"1986","unstructured":"Furcht LT: Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest 55: 505-509, 1986","journal-title":"Lab Invest"},{"key":"313835_CR8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.ph.49.030187.002321","volume":"49","author":"PA D'Amore","year":"1987","unstructured":"D'Amore PA, Thompson RW: Mechanisms of angiogenesis. Ann Rev Physiol 49: 453-464, 1987","journal-title":"Ann Rev Physiol"},{"key":"313835_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0092-8674(91)90642-C","volume":"64","author":"LA Liotta","year":"1991","unstructured":"Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336, 1991","journal-title":"Cell"},{"key":"313835_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnci\/52.2.413","volume":"52","author":"M Gimbrone","year":"1974","unstructured":"Gimbrone M, Cotran R, Leapman S, Folkman J: Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52: 413-419, 1974","journal-title":"J Natl Cancer Inst"},{"key":"313835_CR11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-82-1-96","volume":"82","author":"J Folkman","year":"1975","unstructured":"Folkman J: Tumor angiogenesis: a possible control point in tumor growth. Ann Int Med 82: 96-100, 1975","journal-title":"Ann Int Med"},{"key":"313835_CR12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197108122850711","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971","journal-title":"N Engl J Med"},{"key":"313835_CR13","first-page":"471","volume":"31","author":"H Brem","year":"1980","unstructured":"Brem H, Thompson D, Long DM, Patz A: Human brain tumors: differences in ability to stimulate angiogenesis. Surg Forum 31: 471-473, 1980","journal-title":"Surg Forum"},{"key":"313835_CR14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/neurosurgery\/23.CN_suppl_1.440","volume":"23","author":"S Brem","year":"1976","unstructured":"Brem S: The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg 23: 440-453, 1976","journal-title":"Clin Neurosurg"},{"key":"313835_CR15","first-page":"347","volume":"48","author":"S Brem","year":"1972","unstructured":"Brem S, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48: 347-356, 1972","journal-title":"J Natl Cancer Inst"},{"key":"313835_CR16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(94)91280-7","volume":"344","author":"VW Li","year":"1994","unstructured":"Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82-86, 1994","journal-title":"Lancet"},{"key":"313835_CR17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/BF00230490","volume":"85","author":"P Wesseling","year":"1993","unstructured":"Wesseling P, Vandersteenhoven JJ, Downey BT, Ruiter DJ, Burger PC: Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material. Acta Neuropathol (Berl) 85: 508-514, 1993","journal-title":"Acta Neuropathol (Berl)"},{"key":"313835_CR18","first-page":"532","volume":"34","author":"H Brem","year":"1983","unstructured":"Brem H, Patz J, Tapper D: Detection of human central nervous system tumors: use of migration-stimulating activity of the cerebrospinal fluid. Surg Forum 34: 532-534, 1983","journal-title":"Surg Forum"},{"key":"313835_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410310504","volume":"31","author":"C Guerin","year":"1992","unstructured":"Guerin C, Wolff JE, Laterra J, Drewes LR, Brem H, Goldstein GW: Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids. Ann Neurol 31: 481-487, 1992","journal-title":"Ann Neurol"},{"key":"313835_CR20","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3171\/jns.1995.82.6.1053","volume":"82","author":"PA Grabb","year":"1995","unstructured":"Grabb PA, Gilbert MR: Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier. J Neurosurg 82: 1053-1058, 1995","journal-title":"J Neurosurg"},{"key":"313835_CR21","first-page":"265","volume":"51","author":"JR Less","year":"1991","unstructured":"Less JR, Skalak TC, Sevick EM, Jain RK: Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51: 265-273, 1991","journal-title":"Cancer Res"},{"key":"313835_CR22","first-page":"74","volume":"61","author":"JR Less","year":"1992","unstructured":"Less JR, Skalak TC, Sevick EM, Jain RK: Microvascular network architecture in a mammary carcinoma. Exs 61: 74-80, 1992","journal-title":"Exs"},{"key":"313835_CR23","volume-title":"Tumor blood Flow-II: characterization and modulation. Critical Issues in Tumor Microcirculation, Angiogenesis and Metastasis (conference proceedings)","author":"RK Jain","year":"1994","unstructured":"Jain RK: Tumor blood Flow-II: characterization and modulation. Critical Issues in Tumor Microcirculation, Angiogenesis and Metastasis (conference proceedings) 1994. Cambridge, Massachusetts. Harvard Medical School and the Massachusetts General Hospital"},{"key":"313835_CR24","first-page":"2641","volume":"48","author":"RK Jain","year":"1988","unstructured":"Jain RK: Determinants of tumor blood flow: a review. Cancer Res 48: 2641-2658, 1988","journal-title":"Cancer Res"},{"key":"313835_CR25","first-page":"4564","volume":"54","author":"F Yuan","year":"1994","unstructured":"Yuan F, Salehi HA, Boucher Y, Vasthare US, Tuma RF, Jain RK: Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. Cancer Res 54: 4564-4568, 1994","journal-title":"Cancer Res"},{"key":"313835_CR26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0733-8619(18)30019-7","volume":"13","author":"EP Sipos","year":"1995","unstructured":"Sipos EP, Brem H: New delivery systems for brain tumor therapy. Neurologic Clinics 13: 813-825, 1995","journal-title":"Neurologic Clinics"},{"key":"313835_CR27","first-page":"259","volume":"2","author":"RJ Tamargo","year":"1992","unstructured":"Tamargo RJ, Brem H: Drug delivery to the central nervous system: a review. Neurosurg Quarterly 2: 259-279, 1992","journal-title":"Neurosurg Quarterly"},{"key":"313835_CR28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jnci\/81.8.570","volume":"81","author":"RK Jain","year":"1989","unstructured":"Jain RK: Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst 81: 570-576, 1989","journal-title":"J Natl Cancer Inst"},{"key":"313835_CR29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.30.9.907","volume":"30","author":"FH Hochberg","year":"1980","unstructured":"Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980","journal-title":"Neurology"},{"key":"313835_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.935859","volume":"193","author":"R Langer","year":"1976","unstructured":"Langer R, Brem H, Falterman K, Klein M, Folkman J: Isolation of a cartilage factor that inhibits tumor neovascularization. Science 193: 70-72, 1976","journal-title":"Science"},{"key":"313835_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/263797a0","volume":"263","author":"R Langer","year":"1976","unstructured":"Langer R, Folkman J: Polymers for the sustained release of proteins and other macromolecules. Nature 263: 797-800, 1976","journal-title":"Nature"},{"key":"313835_CR32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02798344","volume":"8","author":"R Langer","year":"1983","unstructured":"Langer R, Murray J: Angiogenesis inhibitors and their delivery systems. Appl Biochem Biotech 8: 9-24, 1983","journal-title":"Appl Biochem Biotech"},{"key":"313835_CR33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4615-3358-0_24","volume-title":"Angiogenesis in Health and Disease","author":"C Guerin","year":"1992","unstructured":"Guerin C, Tamargo RJ, Olivi A, Brem H: Brain tumor angiogenesis: drug delivery and new inhibitors. In: Maragoudakis ME, Gullino P, Lelkes PI (eds) Angiogenesis in Health and Disease. Plenum Press, New York, 1992, pp 265-274"},{"key":"313835_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jbm.820200106","volume":"20","author":"KW Leong","year":"1986","unstructured":"Leong KW, D'Amore P, Marletta M, Langer R: Bioerodible polyanhydrides as drug-carrier matrices. II: Biocompatibility and chemical reactivity. J Biomed Mater Res 20: 51-64, 1986","journal-title":"J Biomed Mater Res"},{"key":"313835_CR35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3171\/jns.1991.74.3.0441","volume":"74","author":"H Brem","year":"1991","unstructured":"Brem H, Mahaley MSJ, Vick NA, Black KL, Schold SCJ, Burger PC, Friedman AH, Ciric IS, Eller TW, Cozzens JW, Kenealy JN: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74: 441-446, 1991","journal-title":"J Neurosurg"},{"key":"313835_CR36","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger P, Walker M, Selker R, Vick N, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold S, Group P-BTT: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345: 1008-1012, 1995","journal-title":"Lancet"},{"key":"313835_CR37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","volume":"41","author":"S Valtonen","year":"1997","unstructured":"Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O, Unsgaard G, Kuurne T: Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study. Neurosurgery 41: 44-49, 1997","journal-title":"Neurosurgery"},{"key":"313835_CR38","first-page":"858","volume-title":"Cancer of the Nervous System","author":"EP Sipos","year":"1997","unstructured":"Sipos EP, Brem H: Angiogenesis in nervous system tumors. In: Black PM, Loeffler JS (eds) Cancer of the Nervous System. Blackwell Scientific Publications, Inc., Cambridge, Massachusetts, 1997, pp 858-873"},{"key":"313835_CR39","first-page":"765","volume":"73","author":"R Eisenstein","year":"1973","unstructured":"Eisenstein R, Sorgente N, Soble LW, Miller A, Kuettner KE: The resistance of certain tissues to invasion: penetrability of explanted tissues by vascularized mesenchyme. Am J Pathol 73: 765-774, 1973","journal-title":"Am J Pathol"},{"key":"313835_CR40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000141835","volume":"48","author":"S Haraldsson","year":"1962","unstructured":"Haraldsson S: The vascular pattern of a growing and full grown human epiphysis. Acta Anat 48: 156, 1962","journal-title":"Acta Anat"},{"key":"313835_CR41","first-page":"551","volume":"99","author":"HJJ Blackwood","year":"1965","unstructured":"Blackwood HJJ: Vascularization of the condylar cartilage of the human mandible. J Anat 99: 551, 1965","journal-title":"J Anat"},{"key":"313835_CR42","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1084\/jem.141.2.427","volume":"141","author":"H Brem","year":"1975","unstructured":"Brem H, Folkman J: Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141: 427-439, 1975","journal-title":"J Exp Med"},{"key":"313835_CR43","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1126\/science.1694043","volume":"248","author":"MA Moses","year":"1990","unstructured":"Moses MA, Sudhalter J, Langer R: Identification of an inhibitor of neovascularization from cartilage. Science 248: 1408-1410, 1990","journal-title":"Science"},{"key":"313835_CR44","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1016\/S0021-9258(17)35639-9","volume":"261","author":"JB Murray","year":"1986","unstructured":"Murray JB, Allison K, Sudhalter J, Langer R: Purification and partial amino acid sequence of a bovine cartilage derived collagenase inhibitor. J Biol Chem 261: 4154-4159, 1986","journal-title":"J Biol Chem"},{"key":"313835_CR45","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.96.6.2645","volume":"96","author":"MA Moses","year":"1999","unstructured":"Moses MA, Wiederschain D, Wu I, Fernandez CA, Ghazizadeh V, Lane WS, Flynn E, Sytkowski A, Tao T, Langer R: Troponin I is present in human cartilage and inhibits angiogenesis. Proc Natl Acad Sci USA 96: 2645-2650, 1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"313835_CR46","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.6192498","volume":"221","author":"J Folkman","year":"1983","unstructured":"Folkman J, Langer R, Linhardt R, Haudenschild C, Taylor S: Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221: 719-725, 1983","journal-title":"Science"},{"key":"313835_CR47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","volume":"230","author":"R Crum","year":"1985","unstructured":"Crum R, Szabo S, Folkman J: A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375-1378, 1985","journal-title":"Science"},{"key":"313835_CR48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00000658-198709000-00016","volume":"206","author":"J Folkman","year":"1987","unstructured":"Folkman J, Ingber DE: Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 206: 374-383, 1987","journal-title":"Ann Surg"},{"key":"313835_CR49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-3565(25)20861-8","volume":"251","author":"M Maragoudakis","year":"1989","unstructured":"Maragoudakis M, Sarmonika M, Panoutsacopoulou M: Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system. J Pharmacol Exp Ther 251: 679-682, 1989","journal-title":"J Pharmacol Exp Ther"},{"key":"313835_CR50","first-page":"445","volume":"61","author":"I Harada","year":"1992","unstructured":"Harada I, Kikuchi T, Shimomura Y, Yamamoto M, Ohno H, Sato N: The mode of action of anti-angiogenic steroid and heparin. Exs 61: 445-448, 1992","journal-title":"Exs"},{"key":"313835_CR51","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/endo-119-4-1768","volume":"119","author":"D Ingber","year":"1986","unstructured":"Ingber D, Madri J, Folkman J: A possible mechanism for inhibition of angiogenesis by angiostatic steroids: induction of capillary basement membrane dissolution. Endocrinology 119: 1768-1775, 1986","journal-title":"Endocrinology"},{"key":"313835_CR52","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/ijc.2910440519","volume":"44","author":"H Ashino-Fuse","year":"1989","unstructured":"Ashino-Fuse H, Takano Y, Oikawa T, Shimamura M, Iwaguchi T: Medroxyprogesterone acetate, an anti-cancer and anti-angiogenic steroid, inhibits the plasminogen activator in bovine endothelial cells. Int J Cancer 44: 859-864, 1989","journal-title":"Int J Cancer"},{"key":"313835_CR53","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/jcp.1041550315","volume":"155","author":"F Blei","year":"1993","unstructured":"Blei F, Wilson EL, Mignatti P, Rifkin DB: Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155: 568-578, 1993","journal-title":"J Cell Physiol"},{"key":"313835_CR54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3171\/jns.1990.73.3.0429","volume":"73","author":"JK Lee","year":"1990","unstructured":"Lee JK, Choi B, Sobel RA, Chiocca EA, Martuza RL: Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisone. J Neurosurg 73: 429-435, 1990","journal-title":"J Neurosurg"},{"key":"313835_CR55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF02427833","volume":"9","author":"RJ Tamargo","year":"1990","unstructured":"Tamargo RJ, Leong KW, Brem H: Growth inhibition of the 9L glioma using polymers to release heparin and cortisone acetate. J Neuro-Oncol 9: 131-138, 1990","journal-title":"J Neuro-Oncol"},{"key":"313835_CR56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3835(84)80023-3","volume":"25","author":"AM Kroon","year":"1984","unstructured":"Kroon AM, Dontje BHJ, Holtrop M, Van den Bogert C: The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics. Cancer Lett 25: 33-40, 1984","journal-title":"Cancer Lett"},{"key":"313835_CR57","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0765.1984.tb01334.x","volume":"19","author":"LM Golub","year":"1984","unstructured":"Golub LM, Ramamurthy N, McNamara TF, Gomes B, Wolff M, Casino A, Kapoor A, Zambon J, Ciancio S, Schneir M: Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease. J Periodontal Res 19: 651-655, 1984","journal-title":"J Periodontal Res"},{"key":"313835_CR58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0765.1985.tb00405.x","volume":"20","author":"LM Golub","year":"1985","unstructured":"Golub LM, Wolff M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J, Ciancio S: Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 20: 12-23, 1985","journal-title":"J Periodontal Res"},{"key":"313835_CR59","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","volume":"2","author":"LM Golub","year":"1991","unstructured":"Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR: Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med 2: 297-321, 1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"313835_CR60","first-page":"323","volume-title":"Analytical Profiles of Drug Substances","author":"V Zbinovsky","year":"1977","unstructured":"Zbinovsky V, Chrekian GP: Minocycline. In: Florey K (eds) Analytical Profiles of Drug Substances. Academic Press, New York, 1977, pp 323-339"},{"key":"313835_CR61","first-page":"1117","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"MA Sande","year":"1990","unstructured":"Sande MA, Mandell GL: Antimicrobial agents: tetracyclines, chloramphenicol, erythromycin, and miscellaneous antibacterial agents. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's The Pharmacological Basis of Therapeutics. Pergamon Press, New York, 1990, pp 1117-1125"},{"key":"313835_CR62","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","volume":"18","author":"LM Golub","year":"1983","unstructured":"Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS: Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 18: 516-526, 1983","journal-title":"J Periodontal Res"},{"key":"313835_CR63","first-page":"672","volume":"51","author":"RJ Tamargo","year":"1991","unstructured":"Tamargo RJ, Bok RA, Brem H: Angiogenesis inhibition by minocycline. Cancer Res 51: 672-675, 1991","journal-title":"Cancer Res"},{"key":"313835_CR64","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/0006-291X(92)91118-A","volume":"188","author":"C Guerin","year":"1992","unstructured":"Guerin C, Laterra J, Masnyk T, Golub LM, Brem H: Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem Biophys Res Commun 188: 740-745, 1992","journal-title":"Biochem Biophys Res Commun"},{"key":"313835_CR65","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF00689966","volume":"30","author":"EA Sotomayor","year":"1992","unstructured":"Sotomayor EA, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei E: Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 30: 377-384, 1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"313835_CR66","first-page":"6702","volume":"52","author":"BA Teicher","year":"1992","unstructured":"Teicher BA, Sotomayor EA, Huang ZD: Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52: 6702-6704, 1992","journal-title":"Cancer Res"},{"key":"313835_CR67","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/ijc.2910570624","volume":"57","author":"BA Teicher","year":"1994","unstructured":"Teicher BA, Holden SA, Ara G, Sotomayor EA, Huang ZD, Chen YN, Brem H: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents. Int J Cancer 57: 920-925, 1994","journal-title":"Int J Cancer"},{"key":"313835_CR68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3171\/jns.1995.82.4.0635","volume":"82","author":"JD Weingart","year":"1995","unstructured":"Weingart JD, Sipos EP, Brem H: The role of minocycline in the treatment of intracranial 9L glioma. J Neurosurg 82: 635-640, 1995","journal-title":"J Neurosurg"},{"unstructured":"Haroun RI, Bettegowda C, Li K, Brem H: Effect of Col-3, an anti-angiogenesis agent, on rat brain endothelial cell proliferation. Submitted for the Annual Meeting of the American Association of Neurological Surgeons 2000. San Francisco, CA, AANS","key":"313835_CR69"},{"key":"313835_CR70","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00126839-199901020-00001","volume":"1","author":"S Wojtowicz-Praga","year":"1999","unstructured":"Wojtowicz-Praga S: Clinical potential of matrix metalloprotease inhibitors. Drugs R D 1: 117-129, 1999","journal-title":"Drugs R D"},{"key":"313835_CR71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/107327489800500201","volume":"5","author":"S Grossman","year":"1998","unstructured":"Grossman S, Fisher J, Piantadosi S, Brem H: The new approaches to brain tumor therapy (NABTT) CNS consortium: organization, objectives, and activities. Cancer Control 5: 107-114, 1998","journal-title":"Cancer Control"},{"key":"313835_CR72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0014-5793(87)80039-X","volume":"214","author":"JD Vassalli","year":"1987","unstructured":"Vassalli JD, Belin D: Amiloride selectively inhibits the urokinase-type plasminogen activator. FEBS Lett 214: 187-191, 1987","journal-title":"FEBS Lett"},{"key":"313835_CR73","first-page":"99","volume":"7","author":"DV Caccamo","year":"1994","unstructured":"Caccamo DV, Keohane ME, McKeever PE: Plasminogen activators and inhibitors in gliomas: an immunohistochemical study. Mod Pathol 7: 99-104, 1994","journal-title":"Mod Pathol"},{"key":"313835_CR74","first-page":"114","volume":"147","author":"DW Hsu","year":"1995","unstructured":"Hsu DW, Efird JT, Hedley-Whyte ET: Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol 147: 114-123, 1995","journal-title":"Am J Pathol"},{"key":"313835_CR75","first-page":"1105","volume":"54","author":"BJ Landau","year":"1994","unstructured":"Landau BJ, Kwaan HC, Verrusio EN, Brem SS: Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. Cancer Res 54: 1105-1108, 1994","journal-title":"Cancer Res"},{"key":"313835_CR76","first-page":"1150","volume":"146","author":"DL Gladson","year":"1995","unstructured":"Gladson DL, Pijuan-Thompson V, Olman MA, Gillespie GY, Yacoub IZ: Upregulation of urokinase and urokinase receptor genes in malignant astrocytoma. Am J Pathol 146: 1150-1160, 1995","journal-title":"Am J Pathol"},{"key":"313835_CR77","first-page":"73","volume":"43","author":"RL Sparks","year":"1983","unstructured":"Sparks RL, Pool TB, Smith NK, Cameron IL: Effects of amiloride on tumor growth and intracellular element content of tumor cells in vivo. Cancer Res 43: 73-77, 1983","journal-title":"Cancer Res"},{"key":"313835_CR78","first-page":"1373","volume":"8","author":"JA Kellen","year":"1988","unstructured":"Kellen JA, Mirakian A, Kolin A: Antimetastatic effect of amiloride in an animal tumour model. Anticancer Res 8: 1373-1376, 1988","journal-title":"Anticancer Res"},{"key":"313835_CR79","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jez.1402670302","volume":"267","author":"MC Alliegro","year":"1993","unstructured":"Alliegro MC, Alliegro MA, Cragoe EJJ, Glaser BM: Amiloride inhibition of angiogenesis in vitro. J Exp Zool 267: 245-252, 1993","journal-title":"J Exp Zool"},{"key":"313835_CR80","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/archopht.1990.01070120122041","volume":"108","author":"RL Avery","year":"1990","unstructured":"Avery RL, Connor TBJ, Farazdaghi M: Systemic amiloride inhibits experimentally induced neovascularization. Arch Ophthalmol 108: 1474-1476, 1990","journal-title":"Arch Ophthalmol"},{"unstructured":"Gibbons MC, Sipos EP, Tyler B, Pinn M, Brem H: The antiangiogenic agent amiloride inhibits tumor growth and prolongs survival in the rat 9L-glioma model (abstract). Annual Meeting of the Congress of Neurological Surgeons 1995. San Francisco, California","key":"313835_CR81"},{"key":"313835_CR82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0090-9556(25)05617-X","volume":"3","author":"AW Pruitt","year":"1975","unstructured":"Pruitt AW, McNay JL, Dayton PG: Transfer characteristics of triamterene and its analogues: central nervous system, placenta, and kidney. Drug Metab Dispos 3: 30-41, 1975","journal-title":"Drug Metab Dispos"},{"key":"313835_CR83","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-2952(90)90323-D","volume":"40","author":"A Garritsen","year":"1990","unstructured":"Garritsen A, Ijzerman AP, Beukers MW, Cragoe EJJ, Soudijn W: Interaction of amiloride and its analogues with adenosine A1 receptors in calf brain. Biochem Pharmacol 40: 827-834, 1990","journal-title":"Biochem Pharmacol"},{"key":"313835_CR84","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/37126","volume":"390","author":"T Boehm","year":"1997","unstructured":"Boehm T, Folkman J, Browder T, O'Reilly MS: Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404-407, 1997","journal-title":"Nature"},{"key":"313835_CR85","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","volume":"91","author":"RJ D'Amato","year":"1994","unstructured":"D'Amato RJ, Loughnan MS, Flynn E, Folkman J: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"313835_CR86","first-page":"184","volume-title":"The Encyclopedia of Controlled Drug Delivery","author":"M Burke","year":"1999","unstructured":"Burke M, Langer R, Brem H: Drug delivery to the central nervous system. In: Mathiowitz E (eds) The Encyclopedia of Controlled Drug Delivery. John Wiley and Sons, Inc., New York, 1999, pp 184-212"},{"key":"313835_CR87","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002800050588","volume":"39","author":"E Sipos","year":"1997","unstructured":"Sipos E, Tyler B, Piantadosi S, Burger P, Brem H: Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother Pharmacol 39: 383-389, 1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"313835_CR88","first-page":"2784","volume":"58","author":"AK Sills","year":"1998","unstructured":"Sills AK, Williams JI, Tyler BM, Epstein DS, Sipos EP, Davis JD, McLane MP, Pitchford S, Cheshire K, Gannon FH, Kinney WA, Chao TL, Donowitz M, Laterra J, Zasloff M, Brem H: Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. Cancer Res 58: 2784-2792, 1998","journal-title":"Cancer Res"},{"key":"313835_CR89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","volume":"79","author":"MS O'Reilly","year":"1994","unstructured":"O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma (see comments). Cell 79: 315-328, 1994","journal-title":"Cell"},{"key":"313835_CR90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O'Reilly","year":"1997","unstructured":"O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997","journal-title":"Cell"},{"key":"313835_CR91","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0022-3468(05)80308-2","volume":"28","author":"H Brem","year":"1993","unstructured":"Brem H, Gresser I, Grosfeld J, Folkman J: The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28: 1253-1257, 1993","journal-title":"J Pediatr Surg"},{"key":"313835_CR92","first-page":"5073","volume":"52","author":"A Gagliardi","year":"1992","unstructured":"Gagliardi A, Hadd H, Collins DC: Inhibition of angiogenesis by suramin. Cancer Res 52: 5073-5075, 1992","journal-title":"Cancer Res"},{"key":"313835_CR93","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09553009114551581","volume":"60","author":"JW Wilks","year":"1991","unstructured":"Wilks JW, Scott PS, Vrba LK, Cocuzza JM: Inhibition of angiogenesis with combination treatments of angiostatic steroids and suramin. Int J Radiat Biol 60: 73-77, 1991","journal-title":"Int J Radiat Biol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006482120049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006482120049\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006482120049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:03:10Z","timestamp":1749632590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006482120049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10]]},"references-count":93,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2000,10]]}},"alternative-id":["313835"],"URL":"https:\/\/doi.org\/10.1023\/a:1006482120049","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2000,10]]}}}